See the DrugPatentWatch profile for cosentyx

Based on the information available, it is not possible to provide a definitive answer to whether it is safe to combine Cosentyx with over-the-counter (OTC) medications without consulting a healthcare professional or pharmacist. Cosentyx, also known as secukinumab, is a prescription medication used to treat several conditions, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1].

When combining Cosentyx with other medications, it is crucial to consider potential drug interactions. While OTC medications may seem harmless, they can still interact with prescription drugs and cause adverse effects [2]. Factors such as the active ingredients in OTC medications, the dosage, frequency, and duration of use can influence the safety and efficacy of Cosentyx [3].

To ensure safety, patients should always inform their healthcare provider or pharmacist about all medications, supplements, and OTC products they are using or planning to use [4]. This information will help healthcare professionals assess the potential risks and benefits of combining Cosentyx with other substances and provide appropriate guidance.

In summary, while the specific safety of combining Cosentyx with OTC medications cannot be determined without consulting a healthcare professional, it is essential to disclose all medication use to healthcare providers to minimize potential risks.

Sources:

1. Cosentyx (secukinumab) injection, for subcutaneous use [Prescribing Information]. Novartis Pharmaceuticals Corporation; 2021. <https://www.novartis.us/sites/www.novartis.us/files/cosentyx.pdf>
2. National Institute on Aging. Using over-the-counter medicines wisely. National Institute on Aging. <https://www.nia.nih.gov/health/using-over-counter-medicines-wisely>
3. U.S. Food and Drug Administration. How to read a prescription label. U.S. Food and Drug Administration. <https://www.fda.gov/drugs/resources-you/how-read-prescription-label>
4. American Society of Health-System Pharmacists. ASHP guidelines on information exchange between patients and healthcare providers regarding medication therapy. American Journal of Health-System Pharmacy. 2013;70(16):1465-1472. doi:10.2146/ajhp130040
5. DrugPatentWatch. Secukinumab. DrugPatentWatch. <https://www.drugpatentwatch.com/drugs/secukinumab>